Get the Stockscreener App
0.6936
0.52%
0.0036
After Hours:
.71
0.0164
+2.36%
Azitra Inc stock is traded at $0.6936, with a volume of 140.21K.
It is up +0.52% in the last 24 hours and down -14.58% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.69
Open:
$0.68
24h Volume:
140.21K
Relative Volume:
0.05
Market Cap:
$2.44M
Revenue:
$1.27M
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.0309
EPS:
-22.4496
Net Cash Flow:
$-10.46M
1W Performance:
-11.42%
1M Performance:
-14.58%
6M Performance:
+137.78%
1Y Performance:
+40.40%
1-Day Range:
$0.68
$0.72
1-Week Range:
$0.68
$0.7642
52-Week Range:
$0.1305
$1.40
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.6936 | 3.73M | 1.27M | -11.28M | -10.46M | -22.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Azitra Inc Stock (AZTR) Latest News
Why retail investors favor Azitra Inc. stockTrade Volume Summary & Stock Market Timing Techniques - newser.com
Is a relief rally coming for Azitra Inc. holdersPortfolio Update Summary & Low Risk High Reward Trade Ideas - newser.com
Custom strategy builders for tracking Azitra Inc.July 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
Can Azitra Inc. recover in the next quarterWeekly Loss Report & Fast Moving Trade Plans - newser.com
O,R&L Commercial leases 12,030 s/f of biomed-tech space to Azitra - NEREJ
Why Azitra Inc stock stays undervalued2025 Breakouts & Breakdowns & Real-Time Volume Triggers - newser.com
Azitra Inc. stock prediction for this week2025 Major Catalysts & Entry Point Confirmation Signals - newser.com
Branford-based biopharma Azitra faces de-listing from NYSE - Hartford Business Journal
Is Azitra Inc stock prepared for digital transitionWeekly Trade Report & Low Risk Entry Point Guides - newser.com
Why Azitra Inc stock stays on buy listsEarnings Growth Report & Safe Capital Growth Tips - newser.com
News impact scoring models applied to Azitra Inc.Earnings Beat & AI Enhanced Execution Alerts - newser.com
Azitra Inc Faces NYSE Compliance Deadline Notice - TipRanks
Azitra receives notice of non-compliance from NYSE American - MSN
Azitra receives NYSE American non-compliance notice By Investing.com - Investing.com Australia
Azitra receives NYSE American non-compliance notice - Investing.com
$4M Equity Threshold: Azitra Receives NYSE Non-Compliance Notice; Plan Due Oct 31, 2025 - Stock Titan
Azitra Inc.’s ATR-04 Study: A Potential Game-Changer for Rash Treatment - TipRanks
How Azitra Inc. stock performs during Fed tightening cyclesWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Can machine learning forecast Azitra Inc. recoveryTreasury Yields & Fast Gaining Stock Reports - newser.com
How sentiment analysis helps forecast Azitra Inc.2025 Volatility Report & Growth-Oriented Investment Plans - newser.com
Azitra (AZTR) Price Target Decreased by 27.99% to 12.23 - Nasdaq
What analysts say about Azitra Inc stockPortfolio Allocation Tips & We Spotted the Next Tesla – See Inside - earlytimes.in
Published on: 2025-09-30 02:04:32 - newser.com
Published on: 2025-09-30 00:42:21 - newser.com
Should You Invest in Munoth Financial Services Limited Before Its Next Earnings ReportInstitutional Holding Changes & Reinvest for Maximum Compounding Returns - earlytimes.in
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Cap:
|
Volume (24h):